Douglas Hogarth to Pulmonary Emphysema
This is a "connection" page, showing publications Douglas Hogarth has written about Pulmonary Emphysema.
Connection Strength
2.348
-
Efficacy and safety of the Spiration Valve System™ for the treatment of severe emphysema in patients with Alpha-1 antitrypsin deficiency (EMPROVE). Respir Med. 2024 04; 224:107565.
Score: 0.821
-
One-Way Endobronchial Valves as Management for Persistent Air Leaks: A Preview of What's to Come? Am J Respir Crit Care Med. 2019 11 15; 200(10):1318-1320.
Score: 0.612
-
Incidence and Outcomes of Revision Bronchoscopies Following Bronchoscopic Lung Volume Reduction (BLVR). J Bronchology Interv Pulmonol. 2025 Jan 01; 32(1).
Score: 0.218
-
Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves. Respir Med. 2024 06; 227:107639.
Score: 0.208
-
Expert Statement: Pneumothorax Associated with One-Way Valve Therapy for Emphysema: 2020 Update. Respiration. 2021; 100(10):969-978.
Score: 0.170
-
Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019 12 01; 200(11):1354-1362.
Score: 0.153
-
A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015 Sep; 46(3):651-62.
Score: 0.111
-
Echocardiography Findings for Pulmonary Hypertension During Workup for Bronchoscopic Lung Volume Reduction. J Bronchology Interv Pulmonol. 2025 Jan 01; 32(1).
Score: 0.054